The Guardian (USA)

US shortage of Adderall is due to increased demand, FDA and drug-makers say

- Samira Asma-Sadeque

An increase in prescripti­ons and an ongoing labor crunch have helped contribute to a nationwide shortage of Adderall across the US.

The Food and Drug Administra­tion (FDA) on Wednesday confirmed the shortage of the drug, used in the treatment of attention deficit hyperactiv­ity disorder (ADHD) and narcolepsy. The FDA said Teva, the largest manufactur­er, is facing “ongoing intermitte­nt manufactur­ing delays”.

While other companies are still producing the drug, the FDA said the supply does not meet demand in the US.

In August, Teva said it was running out of the drug due to a labor shortage, but that the issue had been resolved.

Teva told ABC that supply was not the problem, but increased demand. It said “intermitte­nt backorders” at the company were owing to a “significan­t rise” in prescripti­on rates across the country.

“This can cause some constraint to product availabili­ty,” the company said.

ADHD is mainly diagnosed in children, though many children and adults can go undiagnose­d. Adderall, the common name for amphetamin­e mixed salts, can be administer­ed to children as young as three.

ADDitude Magazine, a publicatio­n and community space for people with ADHD, with nearly 500,000 followers, claims that during the pandemic, diagnoses of the disorder shot up. It suggested parents were now spending more time with their children and thus more closely observing behavioral patterns and struggles with studying and attention. As for adults, their “coping mechanisms and systems broke down”, the magazine said, teaching them about their own attention skills.

The shortage of Adderall is taking a toll on pharmacies and pharmacist­s. One in Baton Rouge told NBC that the “severity” of the shortage is new: “It is something we’ve seen before, but not to the severity, this bad, before,” said Tylan Jones, sales director at Parker’s Pharmacy.

Teva told ABC news it anticipate­s the shortage to be fixed “within months”. The FDA said it was monitoring the issue and working with manufactur­ers to help address the shortage.

 ?? Photograph: JB Reed/ Bloomberg News ?? Adderall, the drug used in the treatment of attention deficit hyperactiv­ity disorder (ADHD) and narcolepsy.
Photograph: JB Reed/ Bloomberg News Adderall, the drug used in the treatment of attention deficit hyperactiv­ity disorder (ADHD) and narcolepsy.

Newspapers in English

Newspapers from United States